Video

Dr Debra Patt on What In-person Attendees Can Expect at the Community Oncology Conference

Debra Patt, MD, PhD, MBA, executive vice president of Texas Oncology, speaks on the key discussions to be held at the 2022 Community Oncology Conference for in-person attendees.

By bringing together administrators, clinicians, and policy makers within community oncology, in-person attendees at the 2022 Community Oncology Conference can discuss issues facing their respective practices and formulate collaborative solutions, said Debra Patt, MD, PhD, MBA, executive vice president of Texas Oncology.


Transcript

What can providers and those involved in community oncology gain by being an in-person attendee at the 2022 Community Oncology Conference?

I think that we've all missed seeing each other for the last 2 years, but we've encountered a whole new slew of challenges. The benefit of going to the Community Oncology Alliance meeting is like no other meeting.

It allows you to meet with like-minded individuals that are in community oncology practice—administrators, clinicians, policy makers—and discuss the problems that you've had and formulate collaborative solutions so you can learn from what everyone else is doing. It's a great forum for that and to discuss with people what resources you've developed and share them.

Related Videos
Picture of San Diego skyline with words ASH Annual Meeting 2024 and health icons overlaid on the bottom
Screenshot of an interview with Amir Ali, PharmD, BCOP
Mansi Shah, MD, assistant professor, Rutgers Cancer Institute of New Jersey
 Alvaro Alencar, MD, associate professor of clinical medicine, chief medical officer, University of Miami Sylvester Comprehensive Cancer Center
Dr Cesar Davila-Chapa
Screenshot of an interview with Nadine Barrett, PhD
Milind Desai, MD
Masanori Aikawa, MD
Neil Goldfarb, GPBCH
Mabel Mardones, MD.
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo